Invention Grant
- Patent Title: Oxadiazole derivative
-
Application No.: US17932871Application Date: 2022-09-16
-
Publication No.: US11718592B2Publication Date: 2023-08-08
- Inventor: Yoshiaki Isobe , Tomoyuki Tanaka , Hirotaka Miyachi
- Applicant: Sumitomo Pharma Co., Ltd.
- Applicant Address: JP Osaka
- Assignee: Sumitomo Pharma Co., Ltd.
- Current Assignee: Sumitomo Pharma Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP 20046138 2020.03.17
- Main IPC: C07D271/06
- IPC: C07D271/06 ; C07D271/10 ; C07D413/04 ; A61P25/12 ; A61P25/24 ; A61P25/10 ; A61P25/08

Abstract:
The present invention relates to a compound of formula (1) wherein Q1 is halogen atom, Q2 is hydrogen atom, etc., X, Y, and Z are nitrogen atom or oxygen atom, and R1 has a given structure, or a pharmaceutically acceptable salt thereof, and a medicament comprising the compound for treating and/or preventing a disease such as epilepsy.
Public/Granted literature
- US20230092498A1 OXADIAZOLE DERIVATIVE Public/Granted day:2023-03-23
Information query